Patents by Inventor Francisco Rafael Nieto-López

Francisco Rafael Nieto-López has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170112829
    Abstract: The present invention refers to the use of compounds binding to the sigma receptor for the treatment or prevention of neuropathic pain resulting from chemotherapy.
    Type: Application
    Filed: January 10, 2017
    Publication date: April 27, 2017
    Applicant: LABORATORIOS DEL DR. ESTEVE, S.A.
    Inventors: José Manuel Baeyens-Cabrera, Helmut H. Buschmann, José-Miguel Vela-Hernandez, Daniel Zamanillo-Castanedo, Francisco Rafael Nieto-López
  • Publication number: 20160220575
    Abstract: The invention refers to the use of a sigma ligand of formula (I) to prevent or treat pain induced by a chemotherapeutic agent, especially pain induced by taxanes, vinca alkaloids or platinum-containing chemotherapeutic drugs.
    Type: Application
    Filed: April 7, 2016
    Publication date: August 4, 2016
    Applicant: Laboratorios del Dr. Esteve, S.A.
    Inventors: José Manuel Baeyens-Cabrera, Helmut Heinrich Buschmann, José Miguel Vela Hernández, Daniel Zamanillo-Castanedo, Francisco-Rafael Nieto-López
  • Publication number: 20160199380
    Abstract: The invention refers to the use of a sigma ligand of formula (I) to prevent or treat pain induced by a chemotherapeutic agent, especially pain induced by taxanes, vinca alkaloids or platinum-containing chemotherapeutic drugs.
    Type: Application
    Filed: March 17, 2016
    Publication date: July 14, 2016
    Applicant: Laboratorios del Dr. Esteve, S.A.
    Inventors: José Manuel Baeyens-Cabrera, Helmut Heinrich Buschmann, José Miguel Vela Hernández, Daniel Zamanillo-Castanedo, Francisco-Rafael Nieto-López
  • Publication number: 20120141606
    Abstract: The invention refers to the use of a sigma ligand of formula (I) to prevent or treat pain induced by a chemotherapeutic agent, especially pain induced by taxanes, vinca alkaloids or platinum-containing chemotherapeutic drugs.
    Type: Application
    Filed: August 12, 2010
    Publication date: June 7, 2012
    Inventors: José Manuel Baeyens-Cabrera, Helmut Heinrich Buschmann, José Miguel Vela Hernández, Daniel Zamanillo-Castanedo, Francisco-Rafael Nieto-López
  • Publication number: 20110052723
    Abstract: The present invention refers to the use of compounds binding to the sigma receptor for the treatment or prevention of neuropathic pain resulting from chemotherapy.
    Type: Application
    Filed: February 17, 2009
    Publication date: March 3, 2011
    Inventors: José Manuel Baeyens-Cabrera, Helmut H. Buschmann, José-Miguel Vela-Hernandez, Daniel Zamanillo-Castanedo, Francisco Rafael Nieto-López